Mycoplasma

Senator Rasha Kelej, CEO of Merck Foundation Named Among the Most Influential African Woman in the World, as “African Woman of the Year 2020”, for the Third Time

Retrieved on: 
Tuesday, February 16, 2021

The campaign, one of the most successful causes that have been taken forward by Merck Foundation, empowers childless and infertile women through access to information, health, change of mindset, and economic empowerment.

Key Points: 
  • The campaign, one of the most successful causes that have been taken forward by Merck Foundation, empowers childless and infertile women through access to information, health, change of mindset, and economic empowerment.
  • More than 18 First Ladies rallied behind the campaign as Ambassadors of Merck More than a Mother campaign, which is very impressive.
  • Some of its innovative initiatives include Health Media Training, Media Recognition Awards, Fashion Awards and Film Awards.
  • Dr. Kelej has also worked closely with local artists to develop local songs to break the stigma of infertility in their communities.

Creative Medical Technology Holdings Identifies Cellular Mechanism of Patented OvaStem® Female Infertility/Ovarian Failure Treatment

Retrieved on: 
Wednesday, February 10, 2021

PHOENIX, Feb. 10, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings announced today new data explaining mechanisms of action of its patented OvaStem female infertility/ovarian failure treatment.

Key Points: 
  • PHOENIX, Feb. 10, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings announced today new data explaining mechanisms of action of its patented OvaStem female infertility/ovarian failure treatment.
  • These cells are a type of immune cell which the Company has previously patented for regeneration of lumbar discs (US Patent #10,842,815).
  • "Cellular therapy is making significant advances in the treatment of cancer, degenerative diseases, and autoimmunity."
  • See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov .

InventHelp Inventor Develops Safety Measure for Oral Sex (LAX-1229)

Retrieved on: 
Thursday, December 17, 2020

The inventor developed THE MASK to provide a safety measure for use during oral sex.

Key Points: 
  • The inventor developed THE MASK to provide a safety measure for use during oral sex.
  • As such, it protects against skin-to-skin contact and the transfer of bodily fluids.
  • Thus, it affords peace of mind for users since it can prevent the spread of sexually transmitted diseases and save lives.
  • The original design was submitted to the Los Angeles sales office of InventHelp.

Global Mycoplasma Testing Markets, 2020-2025 - Globalization of Clinical Trials and R&D and Harmonization of Regulations Resulting in Increased Outsourcing

Retrieved on: 
Monday, December 7, 2020

The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.

Key Points: 
  • The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
  • The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period.

Insights on the Mycoplasma Testing Market 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 - Technavio

Retrieved on: 
Thursday, December 3, 2020

Based on the product, the consumables segment is expected to witness lucrative growth during the forecast period.

Key Points: 
  • Based on the product, the consumables segment is expected to witness lucrative growth during the forecast period.
  • By geography, North America is going to have a lucrative growth during the forecast period.
  • About 40% of the markets overall growth is expected to originate from North America.
  • The US is a key market for mycoplasma testing in North America.

Mycoplasma Testing Market by Product & Service, Technique, Application, End User, Region - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 1, 2020

The "Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period.

Shady Grove Fertility Physicians Recognized as 2020 Top Doctors by Baltimore Magazine

Retrieved on: 
Monday, November 16, 2020

BALTIMORE, Nov. 16, 2020 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) physicians Stephanie Beall, M.D., Ph.D. , and Howard McClamrock, M.D.

Key Points: 
  • BALTIMORE, Nov. 16, 2020 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) physicians Stephanie Beall, M.D., Ph.D. , and Howard McClamrock, M.D.
  • , are recognized as 2020 Top Doctors for infertility in the region by Baltimore magazine.
  • Rounding the corner on its 34th year, the Baltimore Top Doctors honor is bestowed upon by physicians representing dozens of specialties.
  • Dr. Beall seeks to make fertility care accessible for women in the Baltimore region, motivating her to help pass the Maryland fertility preservation bill.

Mycoplasma Testing Market worth $1,095 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 11, 2020

The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019

Key Points: 
  • The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=136509856
    The global mycoplasma testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.
  • In 2019, North America accounted for the largest share of the global mycoplasma testing market.

Mycoplasma Testing Market worth $1,095 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 11, 2020

The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019

Key Points: 
  • The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=136509856
    The global mycoplasma testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.
  • In 2019, North America accounted for the largest share of the global mycoplasma testing market.

Global Mycoplasma Testing Market Size by Product, by Geographic Scope, by End-user, and Forecast

Retrieved on: 
Tuesday, November 10, 2020

The mycoplasma testing market is poised to grow by USD 445.57 million during 2020-2024, progressing at a CAGR of over 11% during the forecast period.

Key Points: 
  • The mycoplasma testing market is poised to grow by USD 445.57 million during 2020-2024, progressing at a CAGR of over 11% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201110005757/en/
    Technavio has announced its latest market research report titled Global Mycoplasma Testing Market 2020-2024 (Graphic: Business Wire)
    Worried about Your Business amidst COVID-19 Impact?
  • The report on the mycoplasma testing market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The mycoplasma testing market analysis includes product segment and geography landscape.